Clinical Characterization of Familial Isolated Pituitary Adenomas

2007 ◽  
Vol 2007 ◽  
pp. 445-446
Author(s):  
M.E. Molitch
Keyword(s):  
Author(s):  
Araceli García-Martínez ◽  
Sandra Silva-Ortega ◽  
Beatriz López-Muñoz ◽  
Óscar Moreno-Pérez ◽  
Irene Monjas ◽  
...  

2013 ◽  
Vol 10 (4) ◽  
pp. 10-15
Author(s):  
Iu V Pankratova ◽  
E G Przhiyalkovskaya ◽  
E A Pigarova ◽  
L K Dzeranova

Despite active research involving familial pituitary adenomas and characterization of five hereditary syndromes, the genetic defects in more than 80 - 95% of patients remain not found. Besides, there is more than 25 cases of coexistence of pheochromocytomas and pituitary adenomas described in literature that up to date is not integrated in any syndrome; genetic defects of such coexistence also aren't defined. However it is supposed that in pituitary tumorigenesis, germline mutations of SDH can take part that is obviously important aspect of further investigation. Germline mutations of SDH were found in patients with different phenotypes of pituitary adenomas. Studying of mutations in genes SDHD, SDHB, SDHC, SDHA and their prevalence in patients with familial pituitary adenomas or with phenotypes of multiple endocrine neoplasia without mutations in MEN1, CDKN1B, PRKAR1A, AIP genes can provide clarity in a role of mutations in SDH in endocrine and in particular pituitary tumorigenesis.


2018 ◽  
Author(s):  
Kinga Nemeth ◽  
Otto Darvasi ◽  
Istvan Liko ◽  
Nikolette Szucs ◽  
Sandor Czirjak ◽  
...  

2008 ◽  
Vol 19 (2) ◽  
pp. 104-111 ◽  
Author(s):  
Stefano La Rosa ◽  
Silvia Uccella ◽  
Linda Dainese ◽  
Silvia Marchet ◽  
Claudia Placidi ◽  
...  

2016 ◽  
Vol 54 (7) ◽  
pp. 4879-4895 ◽  
Author(s):  
Roberto Würth ◽  
Federica Barbieri ◽  
Alessandra Pattarozzi ◽  
Germano Gaudenzi ◽  
Federico Gatto ◽  
...  

1988 ◽  
Vol 66 (6) ◽  
pp. 1265-1271 ◽  
Author(s):  
SHOICHIRO IKUYAMA ◽  
SHOICHI NATORI ◽  
HAJIME NAWATA ◽  
KEN-ICHI KATO ◽  
HIROSHI IBAYASHI ◽  
...  

2008 ◽  
Vol 132 (8) ◽  
pp. 1231-1240 ◽  
Author(s):  
Sylvia L. Asa

Abstract Context.—The sellar region is the site of frequent pathology. The pituitary is affected by a large number of pathologic entities arising from the gland itself and from adjacent anatomical structures including brain, blood vessels, nerves, and meninges. The surgical pathology of this area requires the accurate characterization of primary adenohypophysial tumors, craniopharyngiomas, neurologic neoplasms, germ cell tumors, hematologic malignancies, and metastases as well as nonneoplastic lesions such as cysts, hyperplasias, and inflammatory disorders. Objective.—To provide a practical approach to the diagnosis of pituitary specimens. Data Sources.—Literature review and primary material from the University of Toronto. Conclusions.—The initial examination requires routine hematoxylin-eosin to establish whether the lesion is a primary adenohypophysial proliferation or one of the many other types of pathology that occur in this area. The most common lesions resected surgically are pituitary adenomas. These are evaluated with a number of special stains and immunohistochemical markers that are now available to accurately classify these tumors. The complex subclassification of pituitary adenomas is now recognized to reflect specific clinical features and genetic alterations that predict targeted therapies for patients with pituitary disorders.


2010 ◽  
Vol 21 (7) ◽  
pp. 419-427 ◽  
Author(s):  
Harvinder S. Chahal ◽  
J. Paul Chapple ◽  
Lawrence A. Frohman ◽  
Ashley B. Grossman ◽  
Márta Korbonits

Sign in / Sign up

Export Citation Format

Share Document